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Abstract
Brain monoamines, and serotonin in particular, have repeatedly been shown to be linked to different psychiatric conditions
such as depression, anxiety, antisocial behaviour, and dependence. Many studies have implicated genetic variability in the
genes encoding monoamine oxidase A (MAOA) and the serotonin transporter (5HTT) in modulating susceptibility to these
conditions. Paradoxically, the risk variants of these genes have been shown, in vitro, to increase levels of serotonin, although
many of the conditions are associated with decreased levels of serotonin. Furthermore, in adult humans, and monkeys with
orthologous genetic polymorphisms, there is no observable correlation between these functional genetic variants and the
amount or activity of the corresponding proteins in the brain. These seemingly contradictory data might be explained if the
association between serotonin and these behavioural and psychiatric conditions were mainly a consequence of events taking
place during foetal and neonatal brain development. In this review we explore, based on recent research, the hypothesis that the
dual role of serotonin as a neurotransmitter and a neurotrophic factor has a signiﬁcant impact on behaviour and risk for
neuropsychiatric disorders through altered development of limbic neurocircuitry involved in emotional processing, and
development of the serotonergic neurons, during early brain development.
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Genetic variability affecting serotonin levels
Two of the most studied molecules involved in reg-
ulating levels of serotonin in the brain are the sero-
tonin transporter (5HTT, also known as SLC6A4),
which transports serotonin from the extracellular
space, and monoamine oxidase A (MAOA), the key
enzyme responsible for degrading serotonin. Both
genes encoding these proteins harbour genetic poly-
morphisms in their promoter regions that have been
shown, in vitro, to affect their transcriptional activity
(1–8). These genetic variants have been studied for
their possible involvement in a number of psychiatric
conditions and behavioural traits. The serotonin trans-
porter polymorphism (5HTTLPR) and the mono-
amine oxidase A polymorphism (MAOA-LPR) have
been implicated in conditions and behaviours such
as depression, anxiety, aggression, alcoholism, autism,
suicidality, and impulsiveness (9–15). The relation
between these traits and the genetic variability in
these genes has not always been consistent, and
has displayed both interactions with environmental
factors, and shown different effects in males and
females.
The 5HTTLPR consists of a complex structured
length polymorphism region (9,16). The allelic
variants are usually referred to as S (short, low-
expressing variant) and L (long, high-expressing
variant). The L-allele has further been shown to
encompass a single nucleotide polymorphism (SNP
rs25531) that affects a putative transcription factor
binding site and renders the LG-variant functionally
equivalent to the S-allele (7,17). Interestingly, the
rhesus macaque (Macaca mulatta) has been shown
to contain an orthologous polymorphism in the sero-
tonin transportergenethat has also been shown tohave
a functional effect on transcriptional activity (18).
The MAOA-LPR also constitutes a length poly-
morphism region upstream of the coding region (2).
There are six allelic variants characterized in this
locus, representing 2, 3, 3.5, 4, 5, or 6 copies of a
repeat structure. Functional studies of their relative
effect on transcriptional activity in vitro have
unanimously shown that for the two most common
Correspondence: Niklas Nordquist PhD, Department of Neuroscience, PO Box 593, Biomedical Center, 751 24 Uppsala, Sweden.
E-mail: niklas.nordquist@neuro.uu.se
(Received 8 October 2009; accepted 18 December 2009)
ISSN 0300-9734 print/ISSN 2000-1967 online  2010 Informa UK Ltd. (Informa Healthcare, Taylor & Francis AS)
DOI: 10.3109/03009730903573246variants, the 3-repeat allele displays lower transcrip-
tional activity than the 4-repeat allele (2,3,8). The
2-repeat allele has been reported to have lower tran-
scriptional activity than both the 3- and 4-repeat
alleles (8), whereas the 3.5-repeat allele has been
reported to be equal to the 4-repeat allele (2–3).
The 5-repeat allele has given conﬂicting results (2–
3), whereas the 6-repeat allele has not been function-
ally characterized. Most studies on this MAOA poly-
morphism have been focusing on the 3- and 4-repeat
alleles since the other alleles are rare. Also for this
polymorphism there is an orthologous equivalent in
rhesus macaques with functionality shown in an
in vitro assay (6).
Despite overwhelming amounts of data support-
ing a robust association between these polymorph-
isms and shaping of behavioural traits and
vulnerability to develop psychiatric disorders, the
molecular and biological events leading to the
observed associations are still not fully understood.
A consensus ﬁnding from association studies seems
to hold that the low-expressing variants of these
genes are risk factors for vulnerability to develop
psychiatric disorders, conditions associated with
reduced serotonergic activity, despite the fact that
the low-expressing variants of 5HTTLPR and
MAOA-LPR should intuitively promote increased
serotonergic activity by keeping extracellular levels
of serotonin high. This contradictory relation is
further discussed below. Another seemingly para-
doxical relation, or rather lack of relation, is based
on results from in vivo studies on both humans and
monkeys showing that the genotype in these loci
does not correspond to levels of the corresponding
proteins in the brain of adult individuals, as deter-
mined by positron emission tomography (PET), for
either 5HTT (19–23), or MAOA (24–26), or from
measurements in post-mortem brain tissues (27,28).
There is a possibility, though, that an association
actually exists between these polymorphisms and the
abundance of the respective proteins, which might
be concealed by variability in the number of expres-
sing neurons, two measures that have not yet been
simultaneously assessed. Furthermore, results from
several genetic association studies suggest that these
polymorphisms act differently, in some cases even
in opposite directions, between the sexes (further
discussed below).
Dual functions for serotonin
Serotonin acts as a neurotransmitter released from
serotonergic neurons, which emanate from cell bodies
concentrated in the raphe nuclei in the brain-stem.
Serotonergic projections can be traced to literally all
parts of the brain. The neurocircuits making up the
limbic system, involved in regulation of mood and
behaviour, are particularly rich in serotonergic
projections, where serotonin has been postulated to
act as an inhibitor on the activity of these neuronal
circuits (29). During human embryonic develop-
ment, serotonin is one of the ﬁrst neurotransmitters
to appear, with detectable CNS neurons by 5 weeks
of gestation (30). An important role for serotonin
also as a trophic factor during development has
been described in neural crest cells (31), heart (32),
and in CNS development, which is further discussed
below. Different strategies have been used to
manipulate the effects of serotonin during develop-
ment to understand how and where it exerts its
effects. From these experiments it has become
evident that regulation of serotonin homeostasis is
critical for normal development of the central
nervous system, where dysregulation has been
linked to anatomical, functional, and behavioural
anomalies.
Serotonin excess during brain development
One of the ﬁrst studies demonstrating the importance
of MAOA, and consequently serotonin, in inﬂuencing
human behaviour was based on an observation in a
Dutch family with familial aggregation of impulsive
aggression. The condition was shown to be caused by
a nonsense mutation in the MAOA gene, located on
the X chromosome, which caused male family mem-
bers to become devoid of the enzyme (33). Both
MAOA and 5HTT knock-out mouse models display
elevated levels of brain serotonin during development
and clearly show that this condition is associated with
behavioural changes. The most prominent beha-
vioural effect in MAOA-deﬁcient mice is an increase
in aggressiveness and impulsiveness, possibly com-
bined with a reduction in stress response (34–36). In
5HTT knock-out mouse and rat models, the beha-
vioural outcome is rather different from the MAOA
knock-out in that it induces higher anxiety and inhib-
itory control, combined with reduced aggressiveness
(37,38). Despite the usefulness of these models, lim-
itations in terms of speciﬁc spatio-temporal patterns
of action for the target protein have to be taken into
consideration when interpreting the effects resulting
from complete absence of a speciﬁc protein in a
whole organism throughout all developmental stages.
Using pharmaceutical inhibitors against 5HTT has
been shown to cause analogous depressive-like and
anxious behavioural outcomes as in 5HTT knock-out
mice, treating animals either prenatally (E8–18) (39)
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approximately to the ﬁrst and the third trimester,
respectively, during human foetal development
(41). Inhibition of 5HTT at later time points has
no observable effect on behaviour (40). Also pharma-
cological inhibition of MAOA during foetal develop-
ment has been shown to mimic the effect seen on
aggressive behaviour in MAOA knock-out mice (42).
These results indicate that consequences of excessive
levels of serotonin in the brain on speciﬁc behaviours
later in life are, at least to some extent, determined
during development.
Serotonin deﬁciency during brain development
At the other end of the spectrum, clues to the involve-
mentof serotonin in brain development and behaviour
as a consequence of absence of serotonin have also
been investigated. The development of serotonergic
neurons is dependent on a transcriptional programme,
where the ETS transcription factor Pet-1 (FEV in
humans) has been shown to be a unique marker for
these cells (43,44). In Pet-1-deﬁcient mice, develop-
ment of the serotonin system is abolished, rendering
these animals almost completely devoid of serotonin
neurons and with an 85%–90% reduction of 5HT,
without evident alterations to the cytoarchitecture of
the brain. Behavioural characterization of the Pet-1-
deﬁcient mice established an increased aggressive
behaviour compared to wild-type control mice and
also elevated anxiety-like behaviours (44). Serotonin is
synthesized from the essential amino acid tryptophan
by an enzyme, tryptophan hydroxylase (TPH), which
is present in two forms in humans, where type 1
(TPH1) is the predominant form in peripheral tissues,
whereas type 2 (TPH2) is the rate-limiting enzyme in
CNS serotonin synthesis. In two recent studies, mice
with either a mutant form of the Tph2 gene that
caused an 80% reduction in enzyme activity, or
with a disrupted gene resulting in absence of the
enzyme, were characterized (45–46). These genetic
modiﬁcations to the Tph2 gene caused an 80% reduc-
tion of CNS serotonin in the mutant mice (45) and
total absence inthe Tph2knock-out mice(46). Also in
these animal models, the behavioural consequences of
serotonin depletion during development resulted in
elevated aggressive and anxiety-like behaviours. From
these experiments it seems clear that disruption of
serotonin homeostasis during embryonic and foetal
brain development has an impact on behavioural
traits, which have been fundamental during evolution.
The question arises as to which neuronal circuits
become affected and how the elevated or reduced
levels of serotonin cause these effects.
Mechanisms of altered neuronal development
by serotonin
A well characterized rodent brain region that displays
anatomical alterations in response to elevated seroto-
nin levels during development is the somatosensory
cortex, which, in humans as well as rodents, has a well
deﬁned cytoarchitecture, corresponding to the affer-
ent sensory projections from different areas of the
body. Speciﬁcally the barrel ﬁelds in rodents, inner-
vated by thalamocortical afferent neurons emanating
from the whiskers, have been extensively studied due
to the clear anatomical representation of barrel-like
structures corresponding to individual snout whiskers
in rodents (for review, see Killackey et al. (47)).
Numerous studies in rodents have shown that both
pharmacological and genetic alterations to serotonin
levels during embryonic brain development affect the
formation of barrels in the somatosensory cortex
(48–51). This effect on cortex patterning results
from the inability of thalamocortical afferent neurons
properly to form branching arbours at their terminal
ends (52). These neurons, which are mainly gluta-
matergic, exhibit a transient serotonergic phenotype
during a period of the foetal development, in that they
transiently express 5HTT, MAOA, and VMAT2, and
actively take up extracellular serotonin, which is
stored in vesicles and released at the nerve terminals.
Detailed studies have revealed that the normal devel-
opment of these neurons is dependent on their ability
to capture serotonin through uptake via 5HTT, but is
not dependent on the vesicular release of serotonin
(50). Interestingly, this phenotype, present in 5HTT
and MAOA knock-out mice, was rescued by simul-
taneous depletion of the serotonin receptor 5HT-1B
(53,54), which has been shown to inhibit the release of
glutamate at the thalamocortical nerve terminals (55).
This indicates that the transient serotonin uptake in
these neurons could serve to regulate the receptor
activity by altering the levels of available substrate.
This regulation of neuron development provides a
good model to understand how altered levels of
serotonin could exert its effects.
Neuronal circuits affected by altered serotonin
levels
In vivo functional studies of the human brain, using
functional magnetic resonance imaging (fMRI), have
provided important clues to which speciﬁc brain
regions and functional connections between these
that display serotonin-dependent activity differences
(15,56–62). A recurrent ﬁnding in these studies has
been that the amygdala displays both morphometric
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function of genetic variability in the promoter of both
the MAOA and the 5HTT genes. The amygdala has
an important role in emotional learning and proces-
sing, such as adequate reactions to potentially harmful
situations (63). Healthy subjects with the low-
functioning alleles of MAOA-LPR and 5HTTLPR
have been shown to display increased amygdala acti-
vation to fearful stimuli in facial expression recogni-
tion tasks and also a reduced volume of the amygdala.
In a study by Pezawas et al. it was shown that both the
perigenual anterior cingulate cortex (pACC) and
amygdala showed reduced volume in subjects with
the low-functioning allele of the 5HTTLPR. Further-
more, it was shown that these subjects had lower
‘functional connectivity’ between these regions,
implying that differences in emotional processing of
negative stimuli could, to some extent, be explained
by alterations in a neural circuit connecting these
regions (58). These results were supported by a recent
study by Pacheco et al. that investigated the effect of
the 5HTTLPR on differences to a white matter ﬁbre
tract (uncinate fasciculus) anatomically connecting
amygdala to regions of the prefrontal cortex (62).
Here it was shown that carriers of the low-functioning
5HTTLPR had a reduced white matter connection,
as determined by diffusion MRI, which supports the
previously described reduced functional connectivity
between these regions. Interestingly, a recent study by
Jedema et al., investigating the orthologous 5HTT
polymorphism in rhesus macaques, identiﬁed brain
morphometric differences associated with the
rh5-HTTLPR, analogous to what has been observed
in humans (23). In two studies focusing on the
MAOA-LPR(59,60),brainregionsthatshowedgeno-
typic association in response to emotion-stimulating
tasks overlapped to some extent with those
identiﬁed using the 5HTTLPR. In carriers of the
low-functioning allele of MAOA, both the amygdala
and anterior cingulate cortex displayed reduced vol-
ume compared to carriers of the high-functioning
allele. However, morphometric and functional anal-
yses also identiﬁed other regions affected by MAOA
genotype and, most importantly, that the associations
were conditional on sex. In males, but not in females,
the low-functioning allele of MAOA was associated
with increased volume of the lateral orbitofrontal
cortex (59). Furthermore, in a task promoting
retrieval of aversive memories, this study showed
that amygdala activation in relation to MAOA geno-
type displayed opposite effects between males and
females, where the low-functioning allele in males
was associated with increased amygdala response.
Also the hippocampus displayed sex-dependent
activity response to this task, where male carriers of
the low-functioning allele of MAOA had higher activ-
ity compared to the low-functioning allele, whereas
females did not differ with respect to genotype. In
a no-go ﬂanker task, used to measure inhibitory
control, the low-functioning allele of MAOA in males
was associated with lowered activity in the anterior
cingulate cortex, whereas in females no signiﬁcant
difference was observed. A study by Buckholtz et al.
identiﬁed a neural circuit comprised of the amygdala,
ventromedial prefrontal cortex, and anterior cingulate
cortex. Male carriers of the low-functioning allele of
MAOA showed an increased functional coupling
between the ventromedial prefrontal cortex and the
amygdala, mediated via the anterior cingulate cortex,
in response to a facial expression recognition task
(60). In summary, these fMRI studies clearly show
that speciﬁc brain regions, previously implicated in
emotion processing, and behaviour were functionally
and anatomically affected by genetic variation in the
genes for MAOA and 5HTT, indicating a potential
effect of variable serotonin levels on these structures.
The fact that levels and activity of the MAOA and
5HTT in the adult brain are poorly associated with
genotype (19–26) argues for a developmental effect of
the functional polymorphisms on these neurocircuits
by regulating embryonic/foetal serotonin levels. This
interpretation is supported by recent studies showing
disturbances to the same corticolimbic structures
resulting from absence of the serotonin transporter
during development (64,65) and also from the
identiﬁcation of non-serotonergic neurons in various
limbic areas, transiently expressing the serotonin
transporter (66). Surprisingly, the last-mentioned
study did not observe 5HTT marker expression in
the amygdala during any developmental period. This
result could indicate that the wealth of data associat-
ing the low-functioning variant of 5HTTLPR to
hyper-reactive amygdala response and lower amyg-
dala volume is related to an activity-dependent effect
from the neural projections to and from this region
during development, rather than a developmental
effect of serotonin on the amygdala itself.
Negative feedback on the serotonergic neurons
by serotonin
Serotonin has been shown to modulate the outgrowth
of terminals from serotonergic neurons in an auto-
regulatory feedback loop both directly and indirectly
(for review, see Whitaker-Azmitia (67)). The negative
feedback loop seems to be dependent on the 5HT1A
receptor, which is expressed early during develop-
ment, both on serotonergic neurons and in target
regions of the limbic circuitry. This means that
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could have consequences not only for the neurocir-
cuitry discussed above but also for the size and capac-
ity of the serotonergic system itself. This could in part
explain the paradoxical relation between genetic var-
iants associated with increased levels of available
serotonin (low-functioning alleles of MAOA and
5HTT) and the link to behavioural traits and
psychiatric disorders associated with lower levels of
serotonin in the brain and its metabolite 5HIAA in
cerebrospinal ﬂuid. Or, put another way, the low-
functioning variants of MAOA and 5HTT could be
associated with an increased risk for psychiatric dis-
orders due to increased levels of serotonin during
CNS development, causing functional alterations
to neurocircuits critical for emotional processing
while simultaneously inhibiting the outgrowth of
the serotonergic system.
The effect of serotonin in adulthood
Although much of the discussion above focuses on the
role of serotonin during brain development and the
behavioural consequences, it also has an evident role
in shaping mood and behaviour in adulthood. Two
well studied experimental paradigms for exploring
phenotypic effects of altered serotonin levels in adult-
hood are ‘tryptophan depletion’ and ‘tryptophan
challenge’ (68). These methods for altering central
serotonin levels have speciﬁcally been used to study
depression, since this condition has been strongly
associated with reduced serotonergic neurotransmis-
sion. The tryptophan depletion paradigm has repeat-
edly been associated with a lowering of mood (68,69),
assumed to be a consequence of decreased serotonin
synthesis. Recent studies, however, have provided
results that support a more multi-faceted function
of serotonin in adulthood. A study performed on
healthy women exposed to tryptophan depletion
showed reduction in mood compared to controls,
but this effect was shown to be moderated by geno-
type in the 5HTTLPR. A stress-inducing task caused
a signiﬁcant increase in depressive symptoms and
reduced sense of vigour among carriers of the low-
functioning variant of 5HTTLPR in response to tryp-
tophan depletion, whereas the opposite effect was
observed for carriers of the high-functioning variant
(70). These results are in line with the observations
that the low-functioning variant of 5HTTLPR has
been associated with increased amygdala reactivity
and reduced stress-coping (71). Since there seem
to be a poor correlation between genotype at the
5HTTLPR locus and availability of the serotonin
transporter in the adult brain (19–23), these
differences from modulating serotonin levels in the
adult brain, we hypothesize, are phenotypic conse-
quences arising from a brain that has already been
‘wired’ by variable levels of serotonin during devel-
opment. The situation seems to be even more com-
plex considering that response to tryptophan
depletion has been shown to be conditional on sex.
In a study by Walderhaug et al., women reacted with a
reduction in both mood and impulsiveness, whereas
men showed no difference in mood but with increased
impulsiveness (72). The lowering of mood among
women was associated to 5HTTLPR genotype, where
homozygosity for either the high- or the low-function-
ing variant predicted mood reduction. In this study,
however, no stress-inducing task was used. The oppo-
site paradigm, where healthy volunteers have been
subjected to a tryptophan challenge, shows contra-
dictory effects on depressive mood for females
(73,74). Furthermore, also opposite genotypic effects
among women were observed, where the low-
functioning variant of 5HTTLPR either caused a
lowering of mood (73), or an improved mood (74).
In healthy men, tryptophan challenge induced a
reduction in mood, which was observed to be
modulated by 5HTTLPR genotype, in that carriers
of the high-functioning variant scored higher on
depression (73).
Serotonin and environment interactions
Brain structures involved in emotional regulation
form the neuronal foundation for how we respond
to external stimuli. Above, we have outlined how
serotonin could be involved in modulating some of
these neurocircuits with apparent consequences for
shaping of different aspects of behaviour. From this
follows that genetic variability leading to altered sero-
tonergic neurotransmission will have an impact on
how individuals interpret and respond to environ-
mental cues, such as stressful or fearful stimuli for
example. However, emotional processing in this sense
is not a unilateral event, determined only by the shape
and activity in these neuronal circuits. In a famous
study by Caspi et al., it was shown that the pheno-
typic outcome was modulated through an interplay
between environmental insult and genetic factors
(10). In a sample of male adolescents, antisocial
behaviour was shown to be more common among
carriers of the low-functioning variant of the MAOA-
LPR, given that they had also experienced childhood
maltreatment. Similar results have been observed in
depression, where carriers of the low-functioning
variant of 5HTTLPR were particularly vulnerable
to stressful life events (11). These results imply that
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to be dependent on the environmental context. In
consecutive studies of gene–environment interactions
it has been observed that the effects of variable socio-
environmental factors, in combination with genotype
of the MAOA-LPR and 5HTTLPR, on behavioural
outcomes also display sex differences. A study by
Nilsson et al. replicated the ﬁnding that males
exposed to an unfavourable psycho-social environ-
ment displayed increased antisocial behaviour,
particularly evident among carriers of the low-
functioning variant of the MAOA-LPR (12). In a
follow-up study, it was shown that, among females,
this genetic variant was associated with a lower degree
of antisocial behaviour (75). The ﬁndings of opposite
effects from genetic variability in the MAOA-LPR
between the sexes have also been revealed for
alcohol-related problems in relation to poor psycho-
social environment (14,76). Furthermore, a similar
pattern of sexual dichotomy has been observed for the
5HTTLPR in relation to depressive symptoms (13).
Interestingly, these ﬁndings have been substantiated
by studies in non-human primates, showing that early
rearing conditions had sex-dependent effects on
stress-related response, moderated by a 5HTTLPR-
orthologous polymorphism in rhesus macaques (77).
Plausible explanations for the emergence of these
sexually dimorphic responses might be sought among
a number of different mechanisms and during various
stages in development. Historically, the impact of
gonadal hormones has been a prevailing model for
sexually dimorphic traits, but has over time developed
to include a more complex pattern of interactions
between hormones, sex chromosome-linked gene
expression, and environmental inﬂuences through
epigenetic processes (78,79). There is a clear discrep-
ancy in prevalence for neuropsychiatric disorders
between the sexes, where, for example, females
more often tend to develop major depressive disorder,
generalized anxiety disorder, and post-traumatic
stress disorder, whereas, in males, antisocial person-
ality disorder, childhood attention-defecit hyper-
activity disorder (ADHD), and alcohol and drug
dependence are more frequent (80). Based on recent
literature, an emerging consensus seems to hold that
the male and female brain differ in many aspects with
regard to both anatomical and functional structures
(81). These differences between the sexes might indi-
cate that the aetiology and progression in neuropsy-
chiatric disorders could follow somewhat different
paths with regard to alterations in the CNS. Further-
more, though genetic variants that cause variable
levels of CNS serotonin during brain development
have been shown to regulate the response to early
stressful life events, these aversive stimuli,
irrespectively of genetic background, also seem to
affect postnatal brain development. In a study on
rhesus macaques that were reared either by their
mother or peers, Spinelli et al. could show that the
early life stress associated with peer-rearing led to
stable morphological changes in brain regions previ-
ously shown to be affected in human neuropsychiatric
disorders (82). Other studies in animal models have
shown that early life stress can affect neurotrophic
factors such as brain-derived neurotrophic factor
(BDNF) and nerve growth factor (NGF), known to
be important for development of neurocircuits
involved in emotional processing (83). Alterations
to BDNF during postnatal brain development, in
response to stress, are particularly interesting since
BDNF seems to interact functionally with serotonin
in brain morphogenesis (84), results which are sup-
ported by a human fMRI study where epistasis
between BDNF and 5HTT was shown to affect
both volume and functional connectivity within parts
of the limbic circuitry (85). There are also studies in
animal models showing that early life stress can affect
serotonergic neurotransmission by causing expres-
sional differences to 5HTT and serotonin receptors
(86), and reducing the density of serotonin neuronal
axons to speciﬁc brain regions (87).
Concluding remarks
Serotonin has been shown to be an important factor in
regulating the neuro-development of brain regions
critical for emotional processing. In animal models,
dysregulation of serotonin during these early neuro-
developmental stages have revealed behavioural
outcomes with important parallels to human neuro-
psychiatric disorders. Functional genetic variability in
the genes for MAOA and 5HTT has been ﬁrmly
associated with anatomical and functional differences
in the limbic system in humans, in the absence of an
association to availability or activity of the corre-
sponding proteins, arguing for an effect of these
genetic factors during brain development. Further-
more, the functional genetic variants of MAOA and
5HTT have been shown to modulate the impact of
environmental factors on behavioural traits, in terms
of gene–environment interactions, which in many
cases display apparent sex differences. It also appears
as if these interactions are reciprocal at early ages, in
the sense that genetic factors regulating serotonin
levels result in developmental alterations to speciﬁc
neurocircuits involved in emotional processing, caus-
ing different responses to external stimuli, which has
been observed to have an effect on serotonergic neu-
rotransmission, further affecting on-going neuronal
Role of serotonin during brain development 7development. Future studies on the causal mechan-
isms behind the role of serotonin during brain devel-
opment will hopefully provide knowledge, not only of
how the neurocircuits involved in emotional pro-
cessing work, but also give an improved
understanding of the biological aetiology for neuro-
psychiatric disorders.
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